Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.300
+0.070 (5.69%)
At close: Oct 8, 2025, 4:00 PM EDT
1.310
+0.010 (0.77%)
Pre-market: Oct 9, 2025, 8:12 AM EDT
Boundless Bio Employees
Boundless Bio had 64 employees as of December 31, 2024. The number of employees decreased by 8 or -11.11% compared to the previous year.
Employees
64
Change (1Y)
-8
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,006,094
Market Cap
29.10M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64 | -8 | -11.11% |
| Dec 31, 2023 | 72 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BOLD News
- 2 months ago - Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 4 months ago - Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Boundless Bio Announces Portfolio Prioritization and Runway Extension - GlobeNewsWire
- 5 months ago - Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 6 months ago - Boundless Bio to Participate in the Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 months ago - Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewsWire
- 8 months ago - Boundless Bio to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire
- 8 months ago - Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire